Summit Therapeutics, Inc. (SMMT)
21.95
+1.12
(+5.38%)
USD |
NASDAQ |
Apr 30, 14:22
Summit Therapeutics Total Assets (Quarterly) : 751.18M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 2.408B |
| BioMarin Pharmaceutical, Inc. | 7.594B |
| Eli Lilly & Co. | 112.48B |
| Merck & Co., Inc. | 136.87B |
| Soleno Therapeutics, Inc. | 563.83M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 92.32M |
| Shareholders Equity (Quarterly) | 658.86M |
| Debt to Equity Ratio | 0.0317 |
| Current Ratio | 9.869 |
| Net Debt Paydown Yield | 0.02% |